C4 Therapeutics, Inc. vs. Kymera Therapeutics, Inc. Common Stock
CCCC
C4 Therapeutics, Inc.
$3.15 +1.61%
VS KYMRKymera Therapeutics, Inc. Common Stock
$131.73 +2.82%
Kymera Therapeutics, Inc. Common Stock (KYMR) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| CCCC | KYMR | |
|---|---|---|
| Market Cap | $407.08 million | $11.25 billion |
KYMR leads on 1 of 1 size & scale factors.
Risk & Sentiment
| CCCC | KYMR | |
|---|---|---|
| Short Interest | 0.27% | 0.23% |
KYMR leads on 1 of 1 risk & sentiment factors.
Dig deeper: CCCC overview, CCCC financials, KYMR overview, KYMR financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.